（1）最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法表 示意见的审计报告； （2）最近一个会计年度财务报告内部控制被注册会计师出具否定意见或无法 表示意见的审计报告； （3）上市后最近 36 个月内出现过未按法律法规、《公司章程》、公开承诺 进行利润分配的情形； （4）法律法规规定不得实行股权激励的； 湖南海利化工股份有限公司 董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划（草案修订稿）及首次 授予激励对象名单的核查意见 湖南海利化工股份有限公司（以下简称"公司"）薪酬与考核委员会依据 《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证 券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简 称"《管理办法》"）、《国有控股上市公司（境内）实施股权激励试行办法》 和《关于规范国有控股上市公司实施股权激励制度有关问题的通知》等相关法律、 法规及规范性文件和《湖南海利化工股份有限公司章程》（以下简称"《公司章 程》"）的有关规定，对公司《2025 年限制性股票激励计划（草案修订稿）》 （以下简称"本次激励计划"）及其他相关资料进行了核查，发表核查 ...

安徽六国化工股份有限公司 董事会议事规则（2024 年修订） 第一章 总则 《上海证券交易所股 票上市规则》等法律、法规以及规范性文件的规定和《安徽六国化工股份有限公 司章程》（以下简称"《公司章程》"），制定本规则。 第二章 董事会的组成与职权 第二条 董事会由 9 名董事组成，其中独立董事 3 名，公司设董事长 1 人， 可设副董事长 1 人。董事长和副董事长由董事会以全体董事的过半数选举产生。 第一条 为进一步健全和规范安徽六国化工股份有限公司(以下简称"公司") 董事会的议事方式和决策程序，促使董事和董事会有效地履行其职责，提高董事 会规范运作和科学决策水平，根据《中华人民共和国公司法》 （以下简称"《公司 法》"）、 《中华人民共和国证券法》 （以下简称" 《证券法》"）、 董事会成员中设 1 名由公司职工代表担任的董事。董事会中的职工代表由公 司职工通过职工代表大会、职工大会或者其他形式民主选举产生，无需提交股东 会审议。 第三条 董事会设立审计委员会、提名委员会、战略委员会、薪酬与考核委 员会等 4 个专门委员会（以下统称"各专门委员会"）。各专门委员会对董事会负 责，各专门委员会的提案应提交董 ...

5月28日，亚星化学（600319）发布公告，拟通过全资子公司潍坊亚星新材料有限公司(以下简称"亚星 新材料")引入战略投资者，以优化产业布局和资本结构，推动企业高质量发展。 据公告，本次融资总金额为2.2亿元，其中1.89亿元增加亚星新材料注册资本，剩余3140万元计入资本公 积。资金主要用于亚星新材料的主营业务支出。亚星新材料的投前估值为7亿元。 资料显示，亚星化学主营业务包括离子膜烧碱、高端新材料(如PVDC树脂)及水合肼等化学产品的研发 与生产，属于国有控股企业。 从认购情况看，山东动能嘉元创业投资基金合伙企业(有限合伙)(简称"动能嘉元")拟投资1亿元，认购亚 星新材料新增注册资本8572.7353万元；国运综改致胜(青岛)投资合伙企业(有限合伙)(简称"国运综改") 拟投资8000万元，认购6858.1882万元；山东省国控资本投资有限公司(简称"国控资本")拟投资2500万 元，认购2143.1838万元；山东国投资产管理有限公司(简称"国投资产")拟投资1500万元，认购 1285.9103万元。亚星化学、亚星新材料正与动能嘉元、国运综改、国控资本、国投资产签署相关协 议。 亚星化学表示，本次 ...

Group 1 - The company held its seventh meeting of the third supervisory board, which complied with legal and regulatory requirements [1] - The supervisory board unanimously agreed to abolish the supervisory board and transfer its powers to the audit committee, with amendments to the company's articles of association to take effect upon approval by the shareholders' meeting [1] - The voting results showed 10 votes in favor, 0 against, and 0 abstentions [1] Group 2 - The company agreed to adjust the completion dates for several fundraising investment projects, including the 120,000 tons/year glycine project and the smart factory infrastructure project, to June 2027 [2] - The supervisory board confirmed that the adjustments do not constitute a disguised change in the use of raised funds and are in the best interest of the company and all shareholders [2] - The voting results for this decision were also 10 votes in favor, 0 against, and 0 abstentions [2] Group 3 - The supervisory board approved the continued use of idle raised funds for cash management, allowing for investment in safe and liquid financial products up to RMB 2.6 billion [3] - This decision aims to enhance the efficiency of fund utilization without affecting the construction of fundraising projects [3] - The investment products include structured deposits, time deposits, and agreement deposits, with individual investment terms not exceeding 12 months [3]

Group 1 - The company announced its first share repurchase plan with an estimated amount of RMB 200 million to RMB 300 million [1][2] - The repurchase period is set from April 30, 2025, to April 29, 2026 [1] - The purpose of the repurchase is to reduce registered capital and maintain company value and shareholder rights [1] Group 2 - The company has repurchased a total of 766,700 shares, accounting for 0.04% of the total share capital [2] - The total amount spent on the repurchase so far is RMB 16.0029 million, with a price range of RMB 20.78 to RMB 20.99 per share [2] - The repurchase complies with legal regulations and the company's repurchase plan requirements [2]

Core Viewpoint - The controlling shareholder of Sanyou Chemical plans to invest 100 million yuan in its subsidiary, Tangshan Sanyou Silicon Industry, to enhance its financial strength and support future development needs [1] Group 1: Investment Details - The investment amount is set at 100 million yuan, which will be used to increase the capital of the subsidiary [1] - The capital increase has been approved by the company's independent directors and board of directors, and does not require shareholder meeting approval [1] - The investment price is based on an assessed value, ensuring fair transaction pricing without harming the interests of the company and its shareholders [1] Group 2: Strategic Implications - The capital increase is expected to strengthen the financial position of Tangshan Sanyou Silicon Industry, optimizing its capital structure and enhancing its core competitiveness [1] - This move is also aimed at achieving strategic synergy between the company and its shareholders, promoting the healthy development of the subsidiary [1]

证券代码：688199 证券简称：久日新材 公告编号：2025-031 天津久日新材料股份有限公司 公司将严格按照《上海证券交易所科创板股票上市规则》《上海证券交易所 科创板上市公司自律监管指引第 1 号——规范运作》等相关法律法规以及《天津 久日新材料股份有限公司章程》《天津久日新材料股份有限公司募集资金管理制 度》等相关规定办理相关现金管理业务并及时分析和跟踪现金投资产品运作情 况，如发现或判断有不利因素，将及时采取相应措施，控制投资风险；公司内控 中心为现金管理事项的监督部门，有权对公司现金管理事项进行审计和监督；独 立董事、监事会有权对公司资金使用和现金管理情况进行监督与检查；公司将依 据上海证券交易所的相关规定及时履行信息披露义务。 三、对公司的影响 公司使用部分暂时闲置募集资金进行现金管理是在确保公司募集资金投资 项目所需资金和保证募集资金安全的前提下进行的，不存在长时间的资金闲置， 不存在变相改变募集资金使用用途的情形，不会影响公司日常资金正常周转需要 和募集资金项目的正常运转，亦不会影响公司主营业务的正常发展。同时，使用 部分暂时闲置募集资金进行现金管理，能获得一定的收益，有利于进一步提升公 ...

Core Viewpoint - The stock of Zhongyida has experienced significant volatility, prompting multiple warnings from the company regarding potential suspension of trading due to abnormal price fluctuations and a disconnect from its fundamental performance [3][5][12]. Group 1: Stock Performance - Zhongyida's stock opened lower today, rebounding slightly but still closing down 3.73% at 15.49 CNY per share, with a total market capitalization of 16.59 billion CNY [1]. - Since March 10, the stock has seen a cumulative increase of 299.26%, with the lowest price in February being 3.95 CNY per share and a peak of 18.3 CNY per share this month [1][3]. - The company has issued 18 risk warning announcements since March 10, indicating ongoing concerns about stock price volatility [5]. Group 2: Company Warnings and Fundamentals - Zhongyida has announced that it may apply for a trading suspension if significant abnormal price movements continue, emphasizing that there have been no major changes in its fundamentals [3][5]. - The company is projected to incur losses in 2024, and its price-to-book ratio is significantly higher than the industry average, suggesting that the stock price is not aligned with its fundamental value [3][5]. Group 3: Market Dynamics and Price Trends - The recent surge in Zhongyida's stock price is linked to the rising prices of dipentene, which have increased from 20,000 CNY per ton last October to 80,000 CNY per ton, marking a 300% rise due to supply-demand imbalances [7][10]. - The leading producer, Hubei Yihua, is facing production capacity relocation due to environmental issues, which may lead to a contraction in dipentene supply [7][10]. - The demand for dipentene is also being driven by the rapid growth of PCB photopolymer inks, with the cost of dipentene being a minor component, resulting in lower price sensitivity from downstream users [10][12]. Group 4: Investor Activity - Notable retail investors and funds have been actively trading Zhongyida's stock, contributing to its price volatility [12][13]. - The top ten shareholders include several prominent retail investors, indicating strong interest and potential speculation in the stock [14].

5月26日盘后，公司披露股价异动公告："公司基本面没有发生重大变化，公司2024年度处于亏损状态，公司市 净率远高于行业平均水平。公司股价严重脱离公司基本面，存在市场情绪过热情形及较高的炒作风险。" 据财务数据，2023年、2024年，中毅达均处于亏损状态，净利润则分别亏损1.28亿元、1408.39万元。但今年第 一季度公司归母净利润约为1376.10万元，与上年同期-1039.22万元相比，实现扭亏。 公告中表示，如果未来赤峰瑞阳所处行业经营情况的不利情况未得到扭转，或者赤峰瑞阳的经营状况、盈利能 力没有达到预期，则可能存在继续计提商誉减值的风险。 "如后续公司股票交易进一步出现重大异常，为保护中小投资者合法权益，公司将依规申请停牌核查。敬请广 大投资者理性投资并注意投资风险。"公告提示风险称。 5月26日，近期的牛股中毅达在重挫两日后重整旗鼓，再度以近涨停价收盘，股价报收16.09元/股，涨幅高 达9.9%，全天成交额20.54亿元，换手率为18.78%。 受旗下产品季戊四醇的副产品双季戊四醇价格暴涨影响，以及散户与游资的击鼓传花愈演愈烈，中毅达股价从 3月10日至今涨幅已有近3倍，在26日盘后披露的风 ...

General Overview - Qinghai Salt Lake Industry Co., Ltd. (referred to as "Salt Lake Co.") has established a risk management framework for its commodity derivatives business to enhance control mechanisms and operational processes [1][2][3] - The framework is designed to comply with national laws and regulations, focusing on risk prevention and avoiding speculative trading [1][2] Organizational Structure and Responsibilities - The Shareholders' Meeting and Board of Directors are responsible for overseeing the commodity derivatives business based on its scale [2] - The Marketing Committee serves as the decision-making body for managing commodity derivatives, with specific responsibilities for approving daily hedging plans [2][3] - The Sales Branch is the primary entity responsible for executing the carbon lithium commodity derivatives business and ensuring compliance [2][3] Management Content - The Supply Chain Department is tasked with providing professional support for futures trading and ensuring transaction records are confirmed [3][4] - The Audit and Risk Control Department is responsible for risk management, monitoring the matching of accounts, and reporting to management [3][4] - The Financial Department oversees the funding review and regulatory compliance related to commodity derivatives [3][4] Risk Management Processes - The framework includes comprehensive risk management processes that address market, credit, operational, and liquidity risks [10][11] - Market risk management focuses on monitoring price fluctuations and establishing risk limits for trading [10][11] - Credit risk management involves assessing the creditworthiness of trading partners and taking preventive measures against potential defaults [10][11] Reporting and Evaluation - Monthly and quarterly reports on commodity derivatives activities are required, covering execution status, risk assessments, and financial implications [20][21] - The reports must include analyses of market conditions, compliance issues, and the effectiveness of hedging strategies [20][21] Compliance and Supervision - The framework mandates regular inspections by relevant departments to ensure adherence to regulations and internal policies [12][13] - Any violations of laws or internal guidelines will result in accountability measures against responsible personnel [12][13]